← Evidence map

TrialBlood2010

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms.

Amy V Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

40 papers cite it

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 20304805